Structure‐function analyses of the kit receptor for the steel factor
暂无分享,去创建一个
S. Lev | Y. Yarden | D. Givol | J. Blechman
[1] S. Nishikawa,et al. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor , 1993, Molecular and cellular biology.
[2] M. Brizzi,et al. Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. , 1993, The Journal of biological chemistry.
[3] M. Barbacid,et al. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.
[4] Y Yarden,et al. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity. , 1992, The Journal of biological chemistry.
[5] S. Lev,et al. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. , 1992, The Journal of biological chemistry.
[6] S. Lev,et al. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. , 1992, Journal of Biological Chemistry.
[7] C. Turck,et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways , 1992, Cell.
[8] Y. Yarden,et al. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. , 1992, The EMBO journal.
[9] V. Duronio,et al. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Aaronson,et al. A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. , 1992, The Journal of biological chemistry.
[11] M. Roussel,et al. Random mutagenesis of CSF‐1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. , 1992, The EMBO journal.
[12] D. Williams,et al. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. , 1992, Molecular biology of the cell.
[13] P. Besmer. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor , 1992, Current Biology.
[14] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[15] S. Werner,et al. Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities , 1992, Molecular and cellular biology.
[16] C. Heldin,et al. Activation of the human c‐kit product by ligand‐induced dimerization mediates circular actin reorganization and chemotaxis. , 1991, The EMBO journal.
[17] H. Broxmeyer,et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. , 1991, Cancer cells.
[18] P. Besmer. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. , 1991, Current opinion in cell biology.
[19] A. Ullrich,et al. Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase. , 1991, The Journal of biological chemistry.
[20] A. Ullrich,et al. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. , 1991, The Journal of biological chemistry.
[21] Alastair,et al. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. , 1991, The EMBO journal.
[22] Z. Kelman,et al. Transmembrane signalling receptors for cytokines and growth factors , 1991 .
[23] S. Nishikawa,et al. In utero manipulation of coat color formation by a monoclonal anti‐c‐kit antibody: two distinct waves of c‐kit‐dependency during melanocyte development. , 1991, The EMBO journal.
[24] T. Pawson,et al. The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor , 1991, Molecular and cellular biology.
[25] N. Møłler,et al. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Leder,et al. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.
[27] S. Lev,et al. A specific combination of substrates is involved in signal transduction by the kit‐encoded receptor. , 1991, The EMBO journal.
[28] M. Pazin,et al. A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses. , 1991, The Journal of biological chemistry.
[29] C. Betzel,et al. The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex. , 1990, The Journal of biological chemistry.
[30] W. Rutter,et al. The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.
[31] D. Steiner,et al. Baculovirus-directed expression of the human insulin receptor and an insulin-binding ectodomain. , 1990, The Journal of biological chemistry.
[32] K. Siddle,et al. Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric alpha-subunit. , 1990, The Journal of biological chemistry.
[33] K. Nocka,et al. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. , 1990, Science.
[34] J. Downing,et al. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms , 1989, Molecular and cellular biology.
[35] A. Basu,et al. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. , 1989, Molecular and cellular biology.
[36] A. Ullrich,et al. Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.
[37] D. Housman,et al. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.
[38] W. Rutter,et al. Properties of the insulin receptor ectodomain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[39] V. Chapman,et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.
[40] J. Spiess,et al. Production of an epidermal growth factor receptor-related protein. , 1984, Science.
[41] T. Fleming,et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Russell. Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.